Sort
34,240 grants matching “atherosclerosis”
HIV Protease Inhibitors and Atherosclerosis
$362,000University Of Kentucky · R01 · FY2002 · HL
HIV Protease Inhibitors and Atherosclerosis
$362,000University Of Kentucky · R01 · FY2005 · HL
HIV Protease Inhibitors and Atherosclerosis
$362,000University Of Kentucky · R01 · FY2004 · HL
Functional Analysis of ACAT
$361,982Ta-Yuan Chang · Dartmouth College · R01 · FY2007 · HL
Lung Lysyl Oxidase Regulation by Metal Ion Homeostasis
$361,969Wande Li · Boston University Medical Campus · R01 · FY2010 · ES
Sulfotransferase Expression: Implications for Toxicity
$361,963Melissa A Runge-Morris · Wayne State University · R01 · FY2008 · ES
Vascular Mimetics to Study Inflammation and Atherosclerosis
$361,926Scott Irwin Simon · University Of California At Davis · R01 · FY2015 · HL
Synthetic Mesenchymal Stem Cell Niches for Vascular Therapy
$361,841Wei Tan · University Of Colorado · R01 · FY2013 · HL
Immune Mechanisms in Atherosclerosis
$361,802Cornelia M Weyand · Vanderbilt University · P01 · FY2012 · HL
Dyslipidemia, Lipoic Acid and Diabetic Vascular Complications in Humanized
$361,799Nobuyo Maeda · Univ Of North Carolina Chapel Hill · U01 · FY2006 · HL
Lipid Receptor GPR31 as a Target for Anti-Thrombotic and Stroke Therapy
$361,774Athan Kuliopulos · Oasis Pharmaceuticals · R41 · FY2021 · HL
LRP1 and endothelial function
$361,760Xinchun Pi · Univ Of North Carolina Chapel Hill · R01 · FY2013 · HL
MECHANISM OF OXYSTEROL ACTIVATION OF MEMBRANE CHOLESTEROL
$361,760Daniel S Ory · Washington University · R01 · FY2013 · HL
ALDOSTERONE--A CARDIOVASCULAR RISK FACTOR
$361,755Brigham And Women'S Hospital · R01 · FY2002 · HL
Osteopontin and Collateral Vessel Growth
$361,700William Robert Taylor · Emory University · R01 · FY2009 · HL
Atherogenic mechanisms with homocysteine
$361,697Hong Wang · Temple Univ Of The Commonwealth · R01 · FY2008 · HL
Intermediate cell adhesion: role of calreticulin and LRP
$361,666University Of Alabama At Birmingham · R01 · FY2005 · HL
Recognition of bacterial antigens by NKT cells
$361,600Mitchell Kronenberg · La Jolla Institute For Immunology · R01 · FY2006 · AI
Evaluation of a specific LXR/PPAR agonist for treatment of Alzheimer's disease
$361,569Rajesh H Amin · Auburn University At Auburn · R61 · FY2023 · NS
Genetic Models for the Study of Fibrinolysis in the Vasculature
$361,565Daniel T Eitzman · University Of Michigan At Ann Arbor · P01 · FY2007 · HL
Vascular Mimetics to Study Inflammation and Atherosclerosis
$361,542Scott Irwin Simon · University Of California At Davis · R01 · FY2014 · HL
Genomics dissection of phenotypic diversity and plasticity of innate immune cell
$361,537John Tsang · National Institute Of Allergy And Infectious Diseases · ZIA · FY2011 · AI
Platelet-mediated Modulation of B Cell Immunity
$361,494Timothy L Ratliff · Purdue University · R01 · FY2007 · AI
Morphological and Molecular Imaging System for in vivo Atherosclerosis Research
$361,463Brian E. Applegate · Texas Engineering Experiment Station · R01 · FY2015 · HL
POSTMENOPAUSAL HORMONE REPLACEMENT THERAPY AFTER CABG
$361,422Johns Hopkins University · U01 · FY2000 · HL